Sign In
Buy ALC
$64.22
-0.0600 (-0.0933%)
At Close: Jun 03, 2026
Alcon Announces Results of 2025 Annual General Meeting
04:30pm, Tuesday, 06'th May 2025
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.
Algoma Central Corporation Reports Financial Results for the 2025 First Quarter
09:27am, Friday, 02'nd May 2025
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (TSX: ALC) ("Algoma", the "Company") today reported its results for the three months ended March 31, 2
Algoma Central Corporation and Irving Oil Welcome New Tanker Vessels to Fuel Energy Deliveries
09:35am, Monday, 28'th Apr 2025
SAINT JOHN, New Brunswick--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Irving Oil and Algoma Central Corporation (“Algoma”) (TSX: ALC) welcomed the first of two new product tankers into Saint Jo
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
08:00am, Friday, 25'th Apr 2025
GENEVA--(BUSINESS WIRE)--Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS.
Alcon Publishes Agenda for 2025 Annual General Meeting
01:00am, Friday, 04'th Apr 2025
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.
ALC Stock May Rise With the Introduction of PanOptix Pro in US
09:00am, Thursday, 03'rd Apr 2025
Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter
08:00am, Wednesday, 02'nd Apr 2025
GENEVA--(BUSINESS WIRE)--Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter.
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space
10:10am, Monday, 31'st Mar 2025
ALC, GKOS and REGN are well-positioned to benefit from the evolving space of cell-based ophthalmic therapy.
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?
08:30am, Friday, 28'th Mar 2025
Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of L
Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval
09:45am, Tuesday, 25'th Mar 2025
ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing visual outcomes with cutting-edge innovation.
ALC Stock Rises Following the Merger Agreement With LENSAR
09:36am, Tuesday, 25'th Mar 2025
Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system.
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities
01:00am, Tuesday, 25'th Mar 2025
GENEVA--(BUSINESS WIRE)--Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities.
Alcon Agrees to Acquire LENSAR, Inc.
08:00am, Monday, 24'th Mar 2025
GENEVA, Switzerland & ORLANDO, Fla.--(BUSINESS WIRE)--Alcon Agrees to Acquire LENSAR, Inc.
Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Retinal Surgery Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offerin
